Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
23/10/2026
Hang Seng Tech Index rises over 2%, now at 3,870.180 points; Hang Seng Index now up 0.788%.
Latest
2 m ago
Citi: Chow Tai Fook (01929.HK) 1H FY2027 Profit Alert Beats Expectations; Maintains "Buy" Rating
6 m ago
A presentation by Heineken shows the company has urged British pubs and hospitality venues to adapt to the boom in weight-loss drug use or risk losing customers and seeing revenue decline. This is a rare admission by a major alcohol producer that GLP-1 drugs pose a threat to beer sales. Research by JPMorgan shows that about 10mn people in the US used drugs such as Novo Nordisk's semaglutide-based Ozempic and Wegovy last year. The spread of such drugs is having a knock-on effect on the consumer goods industry, including reducing consumers' cravings for candy and snacks, driving up demand for clothing alterations, and prompting companies to race to launch products that can alleviate the drugs' side effects. Heineken is the world's second-largest brewer, after AB InBev. Heineken told its hospitality and bar industry customers that GLP-1 drugs could reduce the desire to drink alcohol and put pressure on beer and cider sales by making consumers feel full more easily and reducing how much they drink. The company also warned that the traditional consumption occasion of drinking multiple pints in one session may become increasingly difficult to sustain.
8 m ago
Main funds: Shanghai Stock Connect sector net outflow exceeds 10.4 billion
8 m ago
Unitree Technology rose over 16% intraday, with its share price breaking through the 600 yuan mark and gaining over 40% for the week.
9 m ago
Emerging market stocks extend losses, dragged down by AI selloff and oil prices.
See all latest
